Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians

被引:18
作者
Biswas, Arijit [1 ]
Ranjan, Ravi [1 ]
Meena, Arvind [1 ]
Akhter, Suhail [1 ]
Sharma, Vinita [1 ]
Yadav, Birendra Kumar [1 ]
Behari, Madhuri [1 ]
Saxena, Renu [1 ]
机构
[1] All India Inst Med Sci, Dept Hematol, New Delhi 110029, India
关键词
Factor V Leiden mutation; Factor V HR2 Haplotype; Coagulation Inhibitors; Factor VIII levels; Acute phase; Asian-Indians; ACTIVATED PROTEIN-C; FACTOR-V-LEIDEN; ISCHEMIC-STROKE; VENOUS THROMBOEMBOLISM; FACTOR V-R506Q; RESISTANCE; MUTATION; MARKERS; INACTIVATION; THROMBOPHILIA;
D O I
10.1016/j.thromres.2009.02.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Several prothrombotic factors - both hereditary and acquired - are known to cause stroke. Commonly investigated causes are activated protein C resistance, factor V Leiden mutation, factor VIII levels, prothrombin 20210 G-to-A mutation, coagulation inhibitors such as proteins C and S, and anti phospholipid antibodies such as beta(2)-glycoprotein. Objective: The literature on the prevalence of hematological defects pertaining to these variables in the Asian Indian stroke population is limited to a few isolated reports. In the current study we investigate the above-mentioned variables in 120 stroke patients (non-cardioembolic acute-onset stroke) and compare their status with the hematological profile of an equal number of healthy age- and sex-matched controls. Material and Methods: Plasma and blood leukocytes were collected from all patients and controls for performing hematological assays and molecular tests respectively. The mutations were detected using standard polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) procedures. Statistical analysis was done using SPSS version 12.0. Results: Factor V Leiden (prevalence 8.3% in patients) and activated protein C resistance (prevalence 19.6% in patients) both showed a high degree of association (P<0.01) with the disease condition. However, contrary to common expectations, factor V Leiden was observed much less frequently in patients showing activated protein C resistance (10 out of 23; 43.4%) than is commonly observed in the Caucasian population (almost 90%). Post-acute-phase factor VIII levels were also found to be significantly associated with stroke: 125.6 + 21.1% number of profitable positions (NPP) for controls and 136.2 + 28.8% NPP for patients (P = 0.001). Conclusion: factor V mutations, such as factor V Leiden, may be important risk factors for stroke in an Asian Indian population. Activated protein C resistance has a stronger association with stroke than factor V Leiden and may be caused by other factors such as elevated factor VIII levels in the Asian Indian population apart from factor V Leiden itself. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 23 条
[1]   A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype [J].
Bernardi, F ;
Faioni, EM ;
Castoldi, E ;
Lunghi, B ;
Castaman, G ;
Sacchi, E ;
Mannucci, PM .
BLOOD, 1997, 90 (04) :1552-1557
[2]   Factor V Leiden: Is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis? [J].
Biswas, Arijit ;
Bajaj, Jyoti ;
Ranjan, Ravi ;
Meena, Arvind ;
Akhter, Mohd. Suhail ;
Yadav, Birendra Kumar ;
Sharma, Vinita ;
Saxena, Renu .
CLINICA CHIMICA ACTA, 2008, 392 (1-2) :21-24
[3]   Diagnostic testing for coagulopathies in patients with ischemic stroke [J].
Bushnell, CD ;
Goldstein, LB .
STROKE, 2000, 31 (12) :3067-3078
[4]   A novel mutation of Arg306 of factor V gene in Hong Kong Chinese [J].
Chan, WP ;
Lee, CK ;
Kwong, YL ;
Lam, CK ;
Liang, R .
BLOOD, 1998, 91 (04) :1135-1139
[5]   Thrombophilia, clinical factors, and recurrent venous thrombotic events [J].
Christiansen, SC ;
Cannegieter, SC ;
Koster, T ;
Vandenbroucke, JP ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (19) :2352-2361
[6]  
Cushman Mary, 2005, Hematology Am Soc Hematol Educ Program, P452
[7]   Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke [J].
Duran, R ;
Biner, B ;
Demir, M ;
Çeltik, C ;
Karasalihoglu, S .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (01) :83-88
[8]   Prospective study of markers of hemostatic function with risk of ischemic stroke [J].
Folsom, AR ;
Rosamond, WD ;
Shahar, E ;
Cooper, LS ;
Aleksic, N ;
Nieto, FJ ;
Rasmussen, ML ;
Wu, KK .
CIRCULATION, 1999, 100 (07) :736-742
[9]   Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden [J].
Graf, LL ;
Welsh, CH ;
Qamar, Z ;
Marlar, RA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (01) :52-60
[10]  
HENKENS CMA, 1995, THROMB HAEMOSTASIS, V74, P1198